| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.33B | 111.01B | 107.83B | 105.67B | 90.10B | 81.94B |
| Gross Profit | 16.75B | 17.15B | 17.70B | 14.64B | 13.92B | 13.81B |
| EBITDA | 10.54B | 11.01B | 12.10B | 8.42B | 8.62B | 6.35B |
| Net Income | 1.18B | 1.76B | 3.70B | 3.05B | 1.27B | -1.05B |
Balance Sheet | ||||||
| Total Assets | 116.73B | 122.67B | 129.57B | 123.11B | 122.03B | 123.78B |
| Cash, Cash Equivalents and Short-Term Investments | 3.94B | 9.01B | 10.67B | 8.11B | 14.86B | 15.57B |
| Total Debt | 35.74B | 37.19B | 41.69B | 44.01B | 47.85B | 53.45B |
| Total Liabilities | 61.25B | 66.72B | 73.96B | 71.48B | 73.41B | 76.32B |
| Stockholders Equity | 56.43B | 56.89B | 55.60B | 51.62B | 48.59B | 47.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.00B | 5.53B | -3.32B | 4.44B | 1.19B |
| Operating Cash Flow | 0.00 | 10.36B | 13.56B | 2.66B | 8.26B | 5.96B |
| Investing Cash Flow | 0.00 | -6.01B | -7.91B | -5.12B | -3.15B | -3.90B |
| Financing Cash Flow | 0.00 | -6.01B | -3.10B | -4.79B | -5.89B | 6.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ¥62.03B | 8.00 | ― | 2.67% | 6.26% | -11.38% | |
62 Neutral | ¥147.07B | 4.80 | 3.57% | 1.31% | 1.64% | -10.74% | |
62 Neutral | ¥862.98B | 9.64 | 2.55% | 3.51% | 3.91% | -22.16% | |
62 Neutral | ¥120.52B | 6.41 | ― | 3.19% | 4.06% | -73.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥173.01B | 8.74 | 1.66% | 1.53% | -2.89% | -15.89% | |
58 Neutral | ¥25.65B | 47.50 | ― | 3.72% | -2.18% | -77.82% |